Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to -$1.1 million.

  • Bio Key International's Free Cash Flow rose 1334.18% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year increase of 1529.84%. This contributed to the annual value of -$2.9 million for FY2024, which is 2285.8% up from last year.
  • As of Q3 2025, Bio Key International's Free Cash Flow stood at -$1.1 million, which was up 1334.18% from -$881490.0 recorded in Q2 2025.
  • In the past 5 years, Bio Key International's Free Cash Flow registered a high of $295215.0 during Q1 2024, and its lowest value of -$3.2 million during Q1 2021.
  • Over the past 5 years, Bio Key International's median Free Cash Flow value was -$1.4 million (recorded in 2024), while the average stood at -$1.3 million.
  • Within the past 5 years, the most significant YoY rise in Bio Key International's Free Cash Flow was 11530.55% (2024), while the steepest drop was 75383.37% (2024).
  • Over the past 5 years, Bio Key International's Free Cash Flow (Quarter) stood at -$1.9 million in 2021, then dropped by 4.12% to -$2.0 million in 2022, then increased by 21.47% to -$1.5 million in 2023, then surged by 67.08% to -$504564.0 in 2024, then plummeted by 122.78% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q3 2025, -$881490.0 for Q2 2025, and -$839882.0 during Q1 2025.